Molecular pathogenesis of lymphomas of mucosa-associated lymphoid tissue--from (auto)antigen driven selection to the activation of NF-κB signaling.
about
A single center experience: rituximab plus cladribine is an effective and safe first-line therapy for unresectable bronchial-associated lymphoid tissue lymphoma.Mucosa-associated lymphoid tissue lymphoma with unusual 18F-FDG hypermetabolism arising at the colorectal anastomosis.MALT lymphoma: epidemiology, clinical diagnosis and treatment
P2860
Molecular pathogenesis of lymphomas of mucosa-associated lymphoid tissue--from (auto)antigen driven selection to the activation of NF-κB signaling.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Molecular pathogenesis of lymp ...... activation of NF-κB signaling.
@en
type
label
Molecular pathogenesis of lymp ...... activation of NF-κB signaling.
@en
prefLabel
Molecular pathogenesis of lymp ...... activation of NF-κB signaling.
@en
P2093
P2860
P1476
Molecular pathogenesis of lymp ...... activation of NF-κB signaling.
@en
P2093
P2860
P2888
P304
P356
10.1007/S11427-015-4977-2
P577
2015-11-26T00:00:00Z
P5875
P6179
1030818995